Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma: A single institutional study

Jae Lyun Lee, Sung Bae Kim, Hwoon Yong Jung, Seung Il Park, Dong Kwan Kim, Jong Hoon Kim, Ho Young Song, Woo Kun Kim, Jung Shin Lee, Young Il Min

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

A prospective phase II study of neoadjuvant chemoradiotherapy (CRT) for resectable esophageal squamous cell carcinoma was conducted from May 1993 to March 1996. A total of 88 patients fitted the eligibility criteria and were treated with two courses of induction chemotherapy (cisplatin 60 mg/m2/day on day 1 and 5-fluorouracil (5-FU) 1 000 mg/m2/day on days 2-6) with concurrent hyperfractionated radiotherapy (48 Gy/40 fractions/4 weeks) followed by esophagectomy or definitive CRT comprising 4 cycles of cisplatin/5-FU and hyperfractionated radiotherapy (additional 12 Gy) with intracavitary brachytherapy (9 Gy). Clinical response and downstaging were achieved in 83% and 42% of the patients, respectively. With a median follow-up of 77 months, median survival time was 18 months with a 5-year survival rate of 23%. The clinical responses to CRT and surgery were independent prognostic factors for overall survival. Among the intended surgery group (n = 52), 41 (79%) patients underwent surgery and 36 had a resection with a pathologic complete response rate of 43%. When compared with a matched historical control (n = 40), there was a significant survival benefit in the multimodality arm (p = 0.04). This multimodality therapy was feasible and its efficacy was promising, especially when surgical resection was performed. The therapeutic benefit of neoadjuvant CRT remains to be assessed in large well-designed randomized trials, one of which is ongoing at our institution.

Original languageEnglish (US)
Pages (from-to)207-217
Number of pages11
JournalActa Oncologica
Volume42
Issue number3
DOIs
StatePublished - Jul 2 2003
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma: A single institutional study'. Together they form a unique fingerprint.

Cite this